Shopping Cart
- Remove All
- Your shopping cart is currently empty
Glecirasib (KRAS G12C inhibitor 36) is a potent inhibitor of the oncogenic KRAS G12C mutation, a critical Ras protein crucial for cell growth and development. This compound shows promise for investigating cancers mediated by KRAS G12C mutations[1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $6,989 | 1-2 weeks | |
50 mg | $9,789 | 1-2 weeks | |
100 mg | $13,728 | 1-2 weeks |
Description | Glecirasib (KRAS G12C inhibitor 36) is a potent inhibitor of the oncogenic KRAS G12C mutation, a critical Ras protein crucial for cell growth and development. This compound shows promise for investigating cancers mediated by KRAS G12C mutations[1]. |
Alias | KRAS G12C inhibitor 36, JAB-21822 |
Molecular Weight | 640.03 |
Formula | C31H26ClF4N7O2 |
Cas No. | 2657613-87-9 |
Smiles | O=C1N(C=2C(C(=C1C#N)N3CCN(C(C=C)=O)CC3)=CC(Cl)=C(N2)C4=C(F)C(F)=C(F)C(F)=C4N)C5=C(C(C)C)N=CC=C5C |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.